Kate Johnson December 11, 2024 03 Added to Email Alert Glucagon-like peptide 1 (GLP-1) receptor agonists led to a significant reduction in the risk for venous thromboembolism (VTE) among individuals with type 2 diabetes compared with dipeptidyl peptidase 4 (DPP-4) inhibitors, a recent analysis indicated. Overall, GLP-1 agonist use was associated with a 20% reduction...
Tag: <span>Type 2 Diabetes</span>
Post
Analysis offers new explanation for dangerous atherosclerotic plaques in type 2 diabetes
by Lund University Less collagen and vascular smooth muscle cells are associated with future cardiovascular events in type 2 diabetes. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50753-8 People with type 2 diabetes have a higher risk of suffering a stroke, a heart attack and premature death due to atherosclerosis, but it has been unclear what the underlying mechanisms are....
Post
ULTRA-PROCESSED FOODS ARE A DANGER FOR PEOPLE WITH TYPE 2 DIABETES
NOVEMBER 19TH, 2024POSTED BY ESTHER ROBARDS-FORBES – UT AUSTIN (Credit: Getty Images) SHARE THIS ARTICLE You are free to share this article under the Attribution 4.0 International license. TAGS UNIVERSITY UNIVERSITY OF TEXAS AT AUSTIN Consuming more ultra-processed foods—from diet sodas to packaged crackers to certain cereals and yogurts—is closely linked with higher blood sugar levels in people...
Post
Detecting Type 2 Diabetes Through Voice: How Does It Work?
An international study, Colive Voice, presented at the European Association for the Study of Diabetes (EASD) 2024 conference, shows that patients with type 2 diabetes (T2D) have different voice characteristics compared with healthy controls of the same age and gender. These results “open up possibilities for developing a first-line, noninvasive, and rapid screening tool for T2D, feasible with just...
Post
People with type 2 diabetes who eat low-carb may be able to discontinue medication
Credit: CC0 Public Domain Adults with type 2 diabetes on a low-carbohydrate diet may see benefits to their beta-cell function, allowing them to better manage their disease and possibly discontinue medication, according to new research published in the Journal of Clinical Endocrinology & Metabolism. Beta-cells are endocrine cells in the pancreas that produce and release insulin, the hormone...
Post
New anti-obesity drug shows promise in preventing heart failure related to type 2 diabetes
Graphical abstract. Credit: Cell Reports (2024). DOI: 10.1016/j.celrep.2024.114573 A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic heart function in mice with type 2 diabetes independent of its weight loss effects, suggesting the drug may work as a treatment to prevent the most prevalent form of heart failure in people...
Post
Novel procedure combined with semaglutide may eliminate insulin dependency in type 2 diabetes
Credit: Unsplash/CC0 Public Domain Groundbreaking research presented at UEG Week 2024 reveals a promising new treatment strategy for type 2 diabetes (T2D) that could significantly reduce or even eliminate the need for insulin therapy. This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of...
Post
Scientists reveal strong connection between zinc levels and Type 2 Diabetes
The study has significantly elevated science’s comprehension of zinc’s essential role in metabolic processes. (CREDIT: CC BY-SA 3.0)Share this story In an important new study, scientists have found a strong connection between zinc levels in the human body and the risk of developing type 2 diabetes and non-alcoholic fatty liver disease. This research, published in the journal...
Post
How diabetes risk genes make cells less resilient to stress
A graphical representation of pancreatic islet cells attached to strings bobbing up and down like a marionette. Credit: Gloria Fuentes The cells in your pancreas, like people, can only handle so much stress before they start to break down. Certain stressors, such as inflammation and high blood sugar, contribute to the development of type 2...
Post
Glucose-responsive nanotech prevents dangerously low blood sugar
A new nanomedicine may prevent severe hypos in diabetics Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar levels, according to new research. For diabetics, hypoglycemia – low blood glucose – is common, especially for those...